Straits Times Index
3,300.60 -13.45 (-0.41%) Nikkei
39,135.91 +66.23 (+0.17%) Hang Seng
19,207.25 -428.97 (-2.18%) FTSE 100
8,424.20 +3.94 (+0.05%) Bitcoin USD
71,291.13 +4,621.55 (+6.93%) CMC Crypto 200
1,516.10 +161.68 (+17.84%)
Fresenius SE & Co. KGaA (0OO9.IL)
| Previous close | 27.90 |
| Open | 0.00 |
| Bid | 27.47 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 515,309 |
| Market cap | 18.257B |
| Beta (5Y monthly) | 1.07 |
| PE ratio (TTM) | 15.34 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.92 (3.65%) |
| Ex-dividend date | 18 May 2023 |
| 1y target est | N/A |
- Reuters
UPDATE 2-Fresenius raises outlook on strong quarterly results, exits Vamed
German healthcare group Fresenius first-quarter results beat expectations, the company said on Wednesday, citing strong performance at its Kabi and Helios businesses, prompting it to raise its full-year outlook. First-quarter earnings before interest and tax (EBIT) were 633 million euros ($680 million), above analysts' expectations of 606 million euros, according to a consensus of forecasts from Vara Research. In a bid to get leaner, Fresenius also said that it would sell its investment unit, Fresenius Vamed, completing its portfolio restructuring.
- Simply Wall St.
Institutions own 30% of Fresenius SE & Co. KGaA (ETR:FRE) shares but retail investors control 43% of the company
Key Insights Fresenius SE KGaA's significant retail investors ownership suggests that the key decisions are influenced...
- Simply Wall St.
Is Now The Time To Look At Buying Fresenius SE & Co. KGaA (ETR:FRE)?
Today we're going to take a look at the well-established Fresenius SE & Co. KGaA ( ETR:FRE ). The company's stock saw...
